Diclofenac Epolamine
CAS No. 119623-66-4
Diclofenac Epolamine( DHEP | DIEP | diclofenac hydroxyethylpyrrolidine )
Catalog No. M27544 CAS No. 119623-66-4
Diclofenac Epolamine is a non-steroidal anti-inflammatory agent (NSAID) with analgesic and antipyretic actions.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | Get Quote |
|
| 10MG | 51 | Get Quote |
|
| 25MG | 85 | Get Quote |
|
| 50MG | 124 | Get Quote |
|
| 100MG | 178 | Get Quote |
|
| 200MG | 267 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameDiclofenac Epolamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiclofenac Epolamine is a non-steroidal anti-inflammatory agent (NSAID) with analgesic and antipyretic actions.
-
DescriptionDiclofenac Epolamine is a non-steroidal anti-inflammatory agent (NSAID) with analgesic and antipyretic actions.
-
In VitroFlector Patch (Diclofenac epolamine) (1.3% w/w, 24 hours) increases diclofenac partitioning into the skin.Flector Patch (Diclofenac epolamine) (1.3% w/w) loaded by Microemulsion (ME) enhances the transport of drug through skin and sustains to 12 h after removal of ME.
-
In VivoFlector Patch (Diclofenac epolamine) (1.3% w/w, exteral application) displays effective in treating inflammatory conditions. Animal Model:Rat paw edema inflammation model (induced with carrageenan)Dosage:1.3% w/w Administration:Exteral application Result:Inhibited edema and showed anti-inflammatory efficacy at 6 hours after application.
-
SynonymsDHEP | DIEP | diclofenac hydroxyethylpyrrolidine
-
PathwayOthers
-
TargetOther Targets
-
RecptorVoltage-gated sodium channel
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number119623-66-4
-
Formula Weight411.32
-
Molecular FormulaC20H24Cl2N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESOCCN1CCCC1.OC(=O)Cc1ccccc1Nc1c(Cl)cccc1Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Ilyin VI, et al. V102862 (Co 102862): a potent, broad-spectrum state-dependent blocker of mammalian voltage-gated sodium channels. Br J Pharmacol. 2005 Mar;144(6):801-12.
molnova catalog
related products
-
Absinthiin
Absinthiin is a weak HIV-1 protease inhibitor.
-
[D-Trp2,7,9]-Substan...
[D-Trp2,7,9] Substance P is a tachykinin (Neurokinin Receptor) antagonist with Ki values of 1 μM, 1.3 μM, and ~9 μM for NK-1, NK-2,and NK-3 receptor, respectively.
-
THCA-A (CRM)
THCA-A (CRM) is a certified reference material categorized as a phytocannabinoid.1 THCA-A is a common component of hashish but is non-psychoactive until heated via smoking, which converts it to Δ9-THC.
Cart
sales@molnova.com